Climb Bio CLYM Cash Flow Statement (2020-2026)

NASDAQ CLYM
$15.41 +0.82 (+5.63%)
As of: Sep 4, 2026 · 2:21 PM EDT
Reported Financials

Climb Bio Quarterly Cash Flow Statement

Periods 25 quarters
Latest Jun 2026

Climb Bio reported cash from operations of -$10.55M and free cash flow of -$10.24M for the quarter ended Jun 2026, up 5.4% year over year. This cash flow statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-9.38M-10.70M-13.13M-13.55M-8.37M-8.79M-22.54M-5.60M-3.74M-3.77M-1.66M-54.89M-8.95M-8.39M-20.73M-8.50M-12.86M-17.47M-13.70M-13.50M
Share-based Compensation
2.74M1.15M4.28M4.57M4.53M1.90M10.17M5.35M4.89M1.20M4.26M2.83M2.92M1.66M5.56M5.66M10.20M1.04M17.30M19.50M
Cash from Operations
-12.97M-7.88M-10.78M-13.97M-4.17M-8.45M-15.18M-7.96M3.49M-0.95M-1.82M-0.67M-7.55M-5.52M-15.43M-11.15M-12.14M-15.63M-14.38M-10.55M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
-0.08M-0.29M-0.19M-0.10M0.07M0.40M0.49M0.74M0.75M0.35M0.06M0.17M0.53M0.67M0.57M0.52M0.51M0.30M0.39M
Depreciation & Amortization (CF)Depreciation & Amortization
0.04M0.03M0.03M0.04M0.03M
Change in Working Capital
Change in Account Payables
0.42M-0.97M-0.56M0.23M0.41M-0.74M0.11M0.01M-0.14M-0.67M0.02M-1.18M-0.22M0.41M0.07M0.09M-0.39M1.79M-1.41M0.20M
Change in Accured Expenses
-0.62M1.41M0.97M0.50M-1.66M0.61M-1.46M-1.33M-0.49M0.67M-0.74M1.07M0.10M1.02M2.04M-1.09M-0.79M0.22M-1.53M0.94M
Other Working Capital Changes
-0.09M-0.14M-0.12M-0.09M-0.11M-0.10M-0.12M-0.11M-0.12M-0.12M-0.04M-0.04M-0.06M-0.05M-0.06M-0.04M-0.06M0.07M
Investing Activities
Capital Expenditures
0.21M0.01M1.34M0.16M-0.30M
Change in Acquisitions & Divestments
21.55M24.61M55.25M20.99M23.25M36.93M30.50M36.75M13.75M7.00M16.00M25.48M39.08M30.53M31.90M25.60M
Cash from Investing Activities
-106.92M-8.05M-4.04M15.69M8.51M14.28M5.80M-1.60M28.04M36.75M13.75M-9.64M-71.79M-53.41M-42.75M4.79M15.26M25.54M-12.96M-57.26M
Financing Activities
Other financing activities
119.75M0.07M0.01M103.36M
Change in Capital Stock
Net Shares Issued and Repurchased
2.59M1.36M3.15M0.34M0.01M2.03M3.01M5.77M2.21M
Net Equity Issued and Repurchased
0.00M0.02M0.53M0.29M0.01M41.87M2.27M0.04M
Misc.
Cash from Financing Activities
83.14M0.04M0.00M0.02M0.53M0.29M0.01M128.40M2.27M0.04M-0.02M0.01M103.70M
Exchange Rate Effect
0.08M-0.18M-1.05M-0.99M1.81M0.23M0.40M0.00M-0.33M-0.03M0.02M0.11M-0.06M-0.02M0.02M
Change in Cash
-36.66M-15.90M-14.99M0.67M3.34M7.64M-9.15M-9.14M32.06M35.76M11.92M118.11M-76.97M-58.95M-58.21M-6.34M3.12M9.88M-27.33M35.89M
Free Cash Flow
-12.97M-7.88M-10.78M-13.97M-4.17M-8.45M-15.18M-7.96M3.49M-0.95M-1.82M-0.67M-7.55M-5.74M-15.44M-12.49M-12.30M-15.63M-14.38M-10.24M
Net Cash Flow
-36.74M-15.90M-14.81M1.72M4.33M5.83M-9.38M-9.54M32.05M36.09M11.95M118.09M-77.07M-58.89M-58.19M-6.36M3.12M9.88M-27.33M35.89M